Kane Biotech Inc.
KNBIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $939 | $1,613 | $494 | $359 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $131 | $139 | $204 | $88 |
| Inventory | $339 | $335 | $158 | $376 |
| Other Curr. Assets | $262 | $300 | $440 | $206 |
| Total Curr. Assets | $1,672 | $2,387 | $1,295 | $1,029 |
| Property Plant & Equip (Net) | $501 | $855 | $902 | $929 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $570 | $559 | $536 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,069 | $1,424 | $1,461 | $1,465 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,741 | $3,811 | $2,756 | $2,494 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1,038 | $959 | $1,186 |
| Short-Term Debt | $622 | $544 | $490 | $462 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,237 | $403 | $851 | $762 |
| Total Curr. Liab. | $1,858 | $1,984 | $2,301 | $2,410 |
| LT Debt | $1,676 | $2,062 | $1,589 | $1,713 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1,676 | $2,062 | $1,589 | $1,713 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $815 | $844 | $873 |
| Total Liabilities | $3,534 | $4,046 | $3,890 | $4,123 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $27,245 | $27,056 | $25,957 | $24,402 |
| Retained Earnings | -$36,590 | -$35,982 | -$35,634 | -$34,415 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $8,551 | $8,692 | $8,543 | $8,384 |
| Total Equity | -$793 | -$235 | -$1,134 | -$1,629 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,741 | $3,811 | $2,756 | $2,494 |
| Net Debt | $1,358 | $993 | $1,586 | $1,816 |